Covered recipient · General Payments record
JOHN E MULLINAX
Allopathic & Osteopathic Physicians Surgery
General Payments · PY2018–2024
$12,706.03
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,425.00 | 1 |
| Food and Beverage | $580.21 | 7 |
| Travel and Lodging | $13.64 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merit Medical Systems Inc | $1,527.31 | 3 |
| Iovance Biotherapeutics, Inc. | $291.43 | 4 |
| Aadi Bioscience, Inc. | $116.17 | 1 |
| DAVOL INC. | $83.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Aadi Bioscience, Inc. | $116.17 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119596375 | CMS |
| Davol Inc. | $83.94 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127666212 | CMS |
| Iovance Biotherapeutics, Inc. | $65.93 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147112732 | CMS |
| Iovance Biotherapeutics, Inc. | $46.72 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147112736 | CMS |
| Iovance Biotherapeutics, Inc. | $141.99 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147112748 | CMS |
| Iovance Biotherapeutics, Inc. | $36.79 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147112752 | CMS |
| Merit Medical Systems Inc | $88.67 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120959967 | CMS |
| Merit Medical Systems Inc | $1,425.00 | 02/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120959969 | CMS |
| Merit Medical Systems Inc | $13.64 | 02/21/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1120959971 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.